| Patients with normal-range CA19-9 levels represent a distinct subgroup of pancreatic cancer patients | |
| Luo, Guopei; Jin, Kaizhou; Guo, Meng; Cheng, He; Liu, Zuqiang; Xiao, Zhiwen; Lu, Yu; Long, Jiang; Liu, Liang; Xu, Jin | |
| 刊名 | ONCOLOGY LETTERS
 |
| 2017 | |
| 卷号 | 13期号:2 |
| 关键词 | pancreatic adenocarcinoma subtype Lewis carbohydrate antigen 19-9 gemcitabine chemotherapy |
| ISSN号 | 1792-1074 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3615194 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Luo, Guopei,Jin, Kaizhou,Guo, Meng,et al. Patients with normal-range CA19-9 levels represent a distinct subgroup of pancreatic cancer patients[J]. ONCOLOGY LETTERS,2017,13(2). |
| APA | Luo, Guopei.,Jin, Kaizhou.,Guo, Meng.,Cheng, He.,Liu, Zuqiang.,...&Yu, Xianjun.(2017).Patients with normal-range CA19-9 levels represent a distinct subgroup of pancreatic cancer patients.ONCOLOGY LETTERS,13(2). |
| MLA | Luo, Guopei,et al."Patients with normal-range CA19-9 levels represent a distinct subgroup of pancreatic cancer patients".ONCOLOGY LETTERS 13.2(2017). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论